Endogenous Interleukin‐10 in Inflammatory Disorders: Regulatory Roles and Pharmacological Modulation
1996; Wiley; Volume: 796; Issue: 1 Linguagem: Inglês
10.1111/j.1749-6632.1996.tb32590.x
ISSN1749-6632
AutoresMichel Goldman, Arnaud Marchant, Liliane Schandené,
Tópico(s)Reproductive System and Pregnancy
ResumoAnnals of the New York Academy of SciencesVolume 796, Issue 1 p. 282-293 Endogenous Interleukin-10 in Inflammatory Disorders: Regulatory Roles and Pharmacological Modulation MICHEL GOLDMAN, Corresponding Author MICHEL GOLDMAN Department of Immunology Hǒpital Erasme, Université Libre de Bruxelles Brussels, BelgiumAuthor to whom correspondence should be addressed.Search for more papers by this authorARNAUD MARCHANT, ARNAUD MARCHANT Department of Immunology Hǒpital Erasme, Université Libre de Bruxelles Brussels, BelgiumSearch for more papers by this authorLILIANE SCHANDENÉ, LILIANE SCHANDENÉ Department of Immunology Hǒpital Erasme, Université Libre de Bruxelles Brussels, BelgiumSearch for more papers by this author MICHEL GOLDMAN, Corresponding Author MICHEL GOLDMAN Department of Immunology Hǒpital Erasme, Université Libre de Bruxelles Brussels, BelgiumAuthor to whom correspondence should be addressed.Search for more papers by this authorARNAUD MARCHANT, ARNAUD MARCHANT Department of Immunology Hǒpital Erasme, Université Libre de Bruxelles Brussels, BelgiumSearch for more papers by this authorLILIANE SCHANDENÉ, LILIANE SCHANDENÉ Department of Immunology Hǒpital Erasme, Université Libre de Bruxelles Brussels, BelgiumSearch for more papers by this author First published: October 1996 https://doi.org/10.1111/j.1749-6632.1996.tb32590.xCitations: 24AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Moore, K. W., A. O'Garra, R. De Waal Malefyt, P. Vieira and T. R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11: 165–190. 10.1111/j.1600-065X.2008.00711.x CASPubMedWeb of Science®Google Scholar 2 Moore, K. W., P. Vieira, D. F. Fiorentino, M. L. Trounstine, T. A. Khan, and T. R. Mosmann. 1990. Homology of cytokine synthesis inhibitor factor (IL-10) to the Epstein-Barr virus gene BCRF1. Science 248: 1230–1234. 10.1126/science.2161559 CASPubMedWeb of Science®Google Scholar 3 Vieira, P., R. de Waal Malefyt, M. -N. Dang, K. E. Johnson, R. Kastelein, D. F. Fiorentino, J. E. de Vries, M. -G. Roncarolo, T. R. Mosmann and K. W. Moore. 1991. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: Homology to Epstein-Barr virus open reading frame BCRF1. Proc. Natl. Acad. Sci. U. S. A. 88: 1172–1176. 10.1073/pnas.88.4.1172 CASPubMedWeb of Science®Google Scholar 4 Windsor, W. T., R. Syto, A. Tsarbopoulos, R. M. Zhang, J. Durkin, S. Baldwin, S. Paliwal, P. W. Mug, B. Pramanik, P. P. Trotta and S. H. Tindall. 1993. Disulfide bond assignments and secondary structure analysis of human and murine interleukin-10. Biochemistry 32: 8807–8815. 10.1021/bi00085a011 CASPubMedWeb of Science®Google Scholar 5 Kim, J. M., C. I. Brannan, N. G. Copeland, N. A. Jenkins, T. A. Khan and K. W. Moore. 1992. Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. J. Immunol. 148: 3618–3623. CASPubMedWeb of Science®Google Scholar 6 Delprete, G., M. Decarli, F. Almerigogna, M. G. Giudizi, R. Biagiotti and S. Romagnani. 1993. Human IL-10 is produced by both type-I helper (Thl) and type-2 helper (Th2) T-cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 150: 353–360. CASPubMedWeb of Science®Google Scholar 7 Yssel, H., R. De Waal Malefyt, M. G. Roncarolo, J. S. Abrams, R. Lahesmaa, H. Spits and J. E. de Vries. 1992. IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. J. Immunol. 149: 2378–2384. 10.4049/jimmunol.149.7.2378 CASPubMedWeb of Science®Google Scholar 8 de Waal Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor and J. E. De Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174: 1209–1220. 10.1084/jem.174.5.1209 PubMedWeb of Science®Google Scholar 9 Fiorentino, D. F., A. Zlotnik, T. R. Mosmann, M. Howard and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147: 3815–3822. 10.4049/jimmunol.147.11.3815 CASPubMedWeb of Science®Google Scholar 10 O'Garra, A., G. Stapleton, V. Dhar, M. Pearce, J. Schumacher, H. Rugo, D. Barbis, A. Stall, J. Cupp, K. W. Moore, P. Vieira, T. R. Mosmann, A. Whitmore, L. Arnold, G. Haughton and M. Howard. 1990. Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin-10. Int. Immunol. 2: 821–832. 10.1093/intimm/2.9.821 CASPubMedWeb of Science®Google Scholar 11 Benjamin, D., T. J. Knobloch and M. A. Dayton. 1992. Human B-cell interleukin-10-B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10. Blood 80: 1289–1298. CASPubMedWeb of Science®Google Scholar 12 Burdin, N., C. Peronne, J. Banchereau and F. Rousset. 1993. Epstein-Barr virus transformation induces lymphocytes-B to produce human interleukin-10. J. Exp. Med. 177: 295–304. 10.1084/jem.177.2.295 CASPubMedWeb of Science®Google Scholar 13 Enk, A. H. and S. I. Katz. 1992. Identification and induction of keratinocyte-derived IL-10. J. Immunol. 149: 92–95. CASPubMedWeb of Science®Google Scholar 14 Ullrich, S. E. 1994. Mechanism involved in the systemic suppression of antigen-presenting cell function by UV irradiation-Keratinocyte-derived IL-10 modulates antigen-presenting cell function of splenic adherent cells. J. Immunol. 152: 3410–3416. CASPubMedWeb of Science®Google Scholar 15 Fouqueray, B., V. Boutard, C. Philippe, A. Kornreich, A. Marchant, J. Perez, M. Goldman and L. Baud. 1995. Mesangial cell-derived interleukin-10 modulates mesangial cell responses to lipopolysaccharide. Am. J. Pathol. 147: 176–182. CASPubMedWeb of Science®Google Scholar 16 Gotlieb, W., J. Abrams, J. Watson, T. Velu, J. Berek and O. Martinez-Maza. 1992. Presence of IL-10 in the ascites of patients with ovarian and other intra-abdominal cancers. Cytokine 4: 385–390. 10.1016/1043-4666(92)90082-3 CASPubMedWeb of Science®Google Scholar 17 Pisa, P., E. Halapi, E. K. Pisa, E. Gerdin, C. Hising, A. Bucht, B. Gerdin and R. Kiessling. 1992. Selective expression of interleukin-10, interferon-gamma, and granulocyte macrophage colony-stimulating factor in ovarian cancer biopsies. Proc. Natl. Acad. Sci. U. S. A. 89: 7708–7712. 10.1073/pnas.89.16.7708 CASPubMedWeb of Science®Google Scholar 18 Yamamura, M., R. L. Modlin, J. D. Ohmenn and R. L. Moy. 1993. Local expression of antiinflammatory cytokines in cancer. J. Clin. Invest. 91: 1005–1010. 10.1172/JCI116256 CASPubMedWeb of Science®Google Scholar 19 Gastl, G. A., J. S. Abrams, D. M. Nanus, R. Oosterkamp, J. SilveR, F. Liu, M. Chen, A. P. Albino and N. H. Bander. 1993. Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int. J. Cancer 55: 96–101. 10.1002/ijc.2910550118 CASPubMedWeb of Science®Google Scholar 20 Bogdan, C., Y. Vodovotz and C. Nathan. 1991. Macrophage deactivation by interleukin-10. J. Exp. Med. 174: 1549–1555. 10.1084/jem.174.6.1549 CASPubMedWeb of Science®Google Scholar 21 Wang, P., P. Wu, M. I. Siegel, R. W. Egan and M. M. Billah. 1994. IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J. Immunol. 153: 811–816. CASPubMedWeb of Science®Google Scholar 22 Cassatella, M. A., L. Meda, S. Bonora, M. Ceska and G. Constantin. 1993. Interleukin-10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes—Evidence for an autocrine role of tumor necrosis factor and IL-I beta in mediating the production of IL-8 triggered by lipopolysaccharide. J. Exp. Med. 178: 2207–2211. 10.1084/jem.178.6.2207 CASPubMedWeb of Science®Google Scholar 23 Takanaski, S., R. Nonaka, Z. Xing, P. Obyrne, J. Dolovich and M. Jordana. 1994. Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils. J. Exp. Med. 180: 711–715. 10.1084/jem.180.2.711 CASPubMedWeb of Science®Google Scholar 24 Gallinelli, R. T., I. P. Oswald, S. L. James and A. Sher. 1992. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. J. Immunol. 148: 1792–1796. PubMedWeb of Science®Google Scholar 25 Cunha, F. Q., S. Moncada and F. Y. Liew. 1992. Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages. Biochem. Biophys. Res. Commun. 182: 1155–1159. 10.1016/0006-291X(92)91852-H CASPubMedWeb of Science®Google Scholar 26 Mertz, P. M., D. L. Dewitt, W. G. Stetlerstevenson and L. M. Wahl. 1994. Interleukin 10 suppression of monocyte prostaglandin H synthase-2—Mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production. J. Biol. Chem. 269: 21322–21329. CASPubMedWeb of Science®Google Scholar 27 Niiro, H., T. Otsuka, S. Kuga, Y. Nemoto, M. Abe, N. Hara, T. Nakano, T. Ogo and Y. Niho. 1994. IL-10 inhibits prostaglandin E(2) production by lipopolysaccharide-stimulated monocytes. Int. Immunol. 6: 661–664. 10.1093/intimm/6.4.661 CASPubMedWeb of Science®Google Scholar 28 Pradier, O., C. GÉrard, A. Delvaux, M. Lybin, D. Abramowicz, P. Capel, T. Velu and M. Goldman. 1993. Interleukin-10 inhibits the induction of monocyte procoagulant activity by bacterial lipopolysaccharide. Eur. J. Immunol. 23: 2700–2703. 10.1002/eji.1830231048 PubMedWeb of Science®Google Scholar 29 Jenkins, J. K., M. Malyak and W. P. Arend. 1994. The effects of interleukin-10 on interleukin-receptor antagonist and interleukin- 1-beta production in human monocytes and neutrophils. Lymphokine Cytokine Res. 13: 84–89. Google Scholar 30 Cassatella, M. A., L. Meda, S. Gasperini, F. Calzetti and S. Bonora. 1994. Interleukin 10 (IL-10) upregulates IL-I receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation. J. Exp. Med. 179: 1695–1699. 10.1084/jem.179.5.1695 CASPubMedWeb of Science®Google Scholar 31 Geng, Y., E. Gulbins, A. Altman and M. Lotz. 1994. Monocyte deactivation by interleukin 10 via inhibition of tyrosine kinase activity and the Ras signaling pathway. Proc. Natl. Acad. Sci. U. S. A. 91: 8602–8606. 10.1073/pnas.91.18.8602 CASPubMedWeb of Science®Google Scholar 32 Wang, P., P. Wu, M. I. Siegel, R. W. Egan and M. M. Billah. 1995. Interleukin (IL)-l0 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes—1L-10 and IL-4 suppress cytokine synthesis by different mechanisms. J. Biol. Chem. 270: 9558–9563. 10.1074/jbc.270.16.9558 CASPubMedWeb of Science®Google Scholar 33 Liu, Y., S. H. Wei, A. S. Ho, R. De Waal Malefyt and K. W. Moore. 1994. Expression cloning and characterization of a human IL-10 receptor. J. Immunol. 152: 1821–1829. 10.4049/jimmunol.152.4.1821 CASPubMedWeb of Science®Google Scholar 34 Tan, J. C., S. Braun, H. Rong, R. Digiacomo, E. Dolphin, S. Baldwin, S. K. Narula, P. J. Zavodny and C. -C. Chou. 1995. Characterization of recombinant extracellular domain of human interleukin-10 receptor. J. Biol. Chem. 270: 1290612911. Google Scholar 35 de Waal Malefyt, R. D., J. Haanen, H. Spits, M. G. Roncarolo, A. Tevelde, C. Figdor, K. Johnson, R. Kastelein, H. Yssel and J. E. Devries. 1991. Interleukin-10 (IL-10) and viral-IL-10 strongly reduce antigen-specific human T-cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-regulation of class-II major histocompatibility complex expression. J. Exp. Med. 174: 915–924. 10.1084/jem.174.4.915 PubMedWeb of Science®Google Scholar 36 Ding, L., P. S. Linsley, L. Y. Huang, R. N. Germain and E. M. Shevach. 1993. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol. 151: 1224–1234. 10.4049/jimmunol.151.3.1224 CASPubMedWeb of Science®Google Scholar 37 Willems, F., A. Marchant, J. P. Delville, C. GÉrard, A. Delvaux, T. Velu and M. Goldman. 1994. Interleukin-10 inhibits B7 and ICAM-1 expression on human monocytes. Eur. J. Immunol. 24: 1007–1009. 10.1002/eji.1830240435 PubMedWeb of Science®Google Scholar 38 Dandrea, A., M. Asteamezaga, N. M. Valiante, X. J. Ma, M. Kubin and G. Trinchieri. 1993. Interleukin-10 (IL-10) inhibits human lymphocyte interferon-gamma production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178: 1041–1048. Google Scholar 39 Macatonia, S. E., T. M. Doherty, S. C. Knight and A. O'Garra. 1993. Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production. J. Immunol. 150: 3755–3764. 10.4049/jimmunol.150.9.3755 CASPubMedWeb of Science®Google Scholar 40 Caux, C., C. Massacrier, B. Vanbervliet, C. Barthelemy, Y. J. Lw and J. Banchereau. 1994. Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells. Int. Immunol. 6: 1177–1185. 10.1093/intimm/6.8.1177 CASPubMedWeb of Science®Google Scholar 41 Enk, A. H., V. L. Angeloni, M. C. Udey and S. I. Katz. 1993. Inhibition of Langerhans cell antigen-presenting function by IL-10—A role for IL-10 in induction of tolerance. J. Immunol. 151: 2390–2398. CASPubMedWeb of Science®Google Scholar 42 Buelens, C., F. Willems, A. Delvaux, G. PiÉrard, J. -P. Delville, T. Velu and M. Goldman. 1995. Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells. Eur. J. Immunol. 25: 2668–2672. 10.1002/eji.1830250940 PubMedWeb of Science®Google Scholar 43 de Waal Malefyt, R. D., H. Yssel and J. E. De Vries. 1993. Direct effects of IL-10 on subsets of human CD4+ T-cell clones and resting T-cells—Specific inhibition of IL-2 production and proliferation. J. Immunol. 150: 4754–4765. PubMedWeb of Science®Google Scholar 44 SchandenÉ, L., C. Alonso-Vega, F. Willems, C. Gerard, A. Delvaux, T. Velu, R. Devos, M. Deboer and M. Goldman. 1994. B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10. J. Immunol. 152: 4368–4374. CASPubMedWeb of Science®Google Scholar 45 Chen, W. F. and A. Zlotnik. 1991. IL-10—A novel cytotoxic T-cell differentiation factor. J. Immunol. 147: 528–534. CASPubMedWeb of Science®Google Scholar 46 Tan, J. Q., C. G. Larsen, B. Gesser, K. Matsushima and K. Thestruppedersen. 1993. Human IL-10 is a chemoattractant for CD8+ T-lymphocytes and an inhibitor of IL-8-induced CD4+ T-lymphocyte migration. J. Immunol. 151: 4545–4551. CASPubMedWeb of Science®Google Scholar 47 Carson, W. E., M. J. Lindemann, R. Baiocchi, M. Linett, J. C. Tan, C. -C. Chou, S. Narula and M. A. Caligiuri. 1995. The functional characterization of interleukin-10 receptor expression on human natural killer cells. Blood 85: 3577–3585. 10.1182/blood.V85.12.3577.bloodjournal85123577 CASPubMedWeb of Science®Google Scholar 48 Go, N. F., B. E. Castle, R. Barrett, R. Kastelein, W. Dang, T. R. Mosmann, K. W. Moore and M. Howard. 1990. Interleukin-10, a novel B cell stimulatory factor—Unresponsiveness of X-chromosome linked immunodeficiency-B cells. J. Exp. Med. 172: 1625–1631. 10.1084/jem.172.6.1625 CASPubMedWeb of Science®Google Scholar 49 Defrance, T., B. Vanbervliet, F. BriÉre, I. Durand, F. Rousset and J. Banchereau. 1992. Interleukin-10 and transforming growth factor-beta cooperate to induce anti-CD40 activated naive human B-cells to secrete immunoglobulin-A. J. Exp. Med. 175: 671–682. 10.1084/jem.175.3.671 CASPubMedWeb of Science®Google Scholar 50 Rousset, F., E. Garcia, T. Defrance, C. Peronne, N. Vezzio, D. H. Hsu, R. Kastelein, K. W. Moore and J. Banchereau. 1992. Interleukin-10 is a potent growth and differentiation factor for activated human lymphocytes-B. Proc. Natl. Acad. Sci. U. S. A. 89: 1890–1893. 10.1073/pnas.89.5.1890 CASPubMedWeb of Science®Google Scholar 51 te Velde, A. A., R. de Waal Malefyt, R. J. Huijbens, J. E. Devries and C. G. Figdor. 1992. IL-10 stimulates monocyte FcgammaR surface expression and cytotoxic activity—Distinct regulation of antibody-dependent cellular cytotoxicity by IFN-gamma, IL-4, and IL-10. J. Immunol. 149: 4048–4052. PubMedWeb of Science®Google Scholar 52 GÉrard, C., C. Bruyns, A. Marchant, D. Abramowicz, P. Vandenabeele, A. Delvaux, W. Fiers, M. Goldman and T. Velu. 1993. Interleukin-10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177: 547–550. 10.1084/jem.177.2.547 CASPubMedWeb of Science®Google Scholar 53 Howard, M., T. Muchamuel, S. Andrade and S. Menon. 1993. Interleukin-10 protects mice from lethal endotoxemia. J. Exp. Med. 177: 1205–1208. 10.1084/jem.177.4.1205 CASPubMedWeb of Science®Google Scholar 54 Donckier, V., V. Flament, C. GÉrard, D. Abramowicz, P. Vandenabeele, M. Wissing, A. Delvaux, W. Fiers, O. Leo, T. Velu and M. Goldman. 1994. Interleukin-10 modulates the release of cytokines and reduces the shock syndrome induced by anti-CD3 monoclonal antibody in mice. Transplantation 57: 1436–1439. CASPubMedWeb of Science®Google Scholar 55 Powrie, F., S. Menon and R. L. Coffman. 1993. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur. J. Immunol. 23: 2223–2229. 10.1002/eji.1830230926 PubMedWeb of Science®Google Scholar 56 Li, L., J. F. Elliott and T. R. Mosmann. 1994. IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1 cell-induced delayed-type hypersensitivity. J. Immunol. 153: 3967–3978. CASPubMedWeb of Science®Google Scholar 57 Pennline, K. J., E. Roque-Gaffney and M. Monahan. 1994. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin. Immunol. Immunopathol. 71: 169–175. 10.1006/clin.1994.1068 CASPubMedWeb of Science®Google Scholar 58 Rott, O., B. Fleisher and E. Cash. 1994. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 24: 1434–1440. 10.1002/eji.1830240629 PubMedWeb of Science®Google Scholar 59 Mignon-Godefroy, K., O. Rott, M. -P. Brazillet and J. Charreire. 1995. Curative and protective effects of IL-10 in experimental autoimmune thyroiditis (EAT). Evidence for IL-10-enhanced cell death in EAT. J. Immunol. 154: 6634–6643. CASPubMedWeb of Science®Google Scholar 60 Wogensen, L., M. S. Lee and N. Sarvetnick. 1994. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in non-obese diabetic mice. J. Exp. Med. 179: 1379–1384. 10.1084/jem.179.4.1379 CASPubMedWeb of Science®Google Scholar 61 KhÜn, R., J. LÖhler, D. Rennick, K. Rajewsky and W. MÜller. 1993. Interleukin10-deficient mice develop chronic enterocolitis. Cell 75: 263–274. 10.1016/0092-8674(93)80068-P PubMedWeb of Science®Google Scholar 62 Marchant, A., C. Bruyns, P. Vandenabeele, M. Ducarme, C. GÉrard, A. Delvaux, D. de Groote, D. Abramowicz, T. Velu and M. Goldman. 1994. IL-10 controls IFN-γ and TNF production during experimental endotoxemia. Eur. J. Immunol. 24: 1167–1171. 10.1002/eji.1830240524 CASPubMedWeb of Science®Google Scholar 63 Florquin, S., Z. Amraou, D. Abramowicz, and M. Goldman. 1994. Systemic release and protective role of IL-10 in staphylococcal enterotoxin B-induced shock in mice. J. Immunol. 153: 2618–2623. CASPubMedWeb of Science®Google Scholar 64 Marchant, A., J. DeviÉre, B. Byl, D. de Groot, J. -L. Vincent and M. Goldman. 1994. Interleukin-10 production during septicaemia. Lancet 343: 707–708. 10.1016/S0140-6736(94)91584-9 CASPubMedWeb of Science®Google Scholar 65 Derkx, B., A. Marchant, M. Goldman, R. Bijlmer and S. van Deventer. 1995. High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock. J. Infect. Dis. 171: 229–232. 10.1093/infdis/171.1.229 PubMedWeb of Science®Google Scholar 66 Marchant, A., M. -L. AlÉgre, A. Hakim, G. PiÉrard, G. MarÉcaux, G. Friedman, D. de Groote, R. J. Kahn, J. -L. Vincent and M. Goldman. 1995. Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock. J. Clin. Immunol. 15: 266–273. 10.1007/BF01540884 CASPubMedWeb of Science®Google Scholar 67 Beutler, B. and G. E. Grau. 1993. Tumor necrosis factor in the pathogenesis of infectious diseases. Crit. Care Med. 21: S423–S435. 10.1097/00003246-199310001-00003 CASPubMedWeb of Science®Google Scholar 68 Murray, H. W. 1994. Interferon-gamma and host antimicrobial defense: Current and future clinical applications. Am. J. Med. 97: 459–467. 10.1016/0002-9343(94)90326-3 CASPubMedWeb of Science®Google Scholar 69 Greenberger, M. J., R. M. Strieter, S. L. Kunkel, J. M. Danforth, R. E. Goodman, and T. J. Standiford. 1995. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J. Immunol. 155: 722–729. CASPubMedWeb of Science®Google Scholar 70 Denis, M. and E. Ghadirian. 1993. IL-10 neutralization augments mouse resistance to systemic mycobacterium avium infections. J. Immunol. 151: 5425–5430. CASPubMedWeb of Science®Google Scholar 71 Ferguson, T. A., P. Dube and T. S. Griffith. 1994. Regulation of contact hypersensitivity by interleukin 10. J. Exp. Med. 179: 1597–1604. 10.1084/jem.179.5.1597 CASPubMedWeb of Science®Google Scholar 72 Katsikis, P. D., C. Q. Chu, F. M. Brennan, R. N. Maini and M. Feldmann. 1994. Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J. Exp. Med. 179: 1517–1527. 10.1084/jem.179.5.1517 CASPubMedWeb of Science®Google Scholar 73 Maini, R. N., M. J. Elliott, P. J. Charles and M. Feldmann. 1994. Immunological intervention reveals reciprocal roles for tumor necrosis factor-α and interleukin-10 in rheumatoid arthritis and systemic lupus erythematosus. Springer Semin. Immunopathol. 16: 327–336. 10.1007/BF00197526 CASPubMedWeb of Science®Google Scholar 74 Kasama, T., R. M. Strieter, N. W. Lukacs, P. M. Lincoln, M. D. Burdick and S. L. Kunkel. 1995. Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. J. Clin. Invest. 95: 2868–2876. 10.1172/JCI117993 CASPubMedWeb of Science®Google Scholar 75 Shanley, T. P., H. Schmal, H. P. Friedl, M. L. Jones and P. A. Ward. 1995. Regulatory effects of intrinsic IL-10 in IgG immune complex-induced lung injury. J. Immunol. 154: 3454–3460. 10.4049/jimmunol.154.7.3454 CASPubMedWeb of Science®Google Scholar 76 Zuany-Amorim, C., S. HallÉ, D. Leduc, C. Dumarey, M. Huerre, B. B. Vargaftig and M. Pretolani. 1995. Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice. J. Clin. Invest. 95: 2644–2651. 10.1172/JCI117966 CASPubMedWeb of Science®Google Scholar 77 Ishida, H., T. Muchamuel, S. Sakaguchi, S. Andrade, S. Menon and M. Howard. 1994. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W Fl Mice. J. Exp. Med. 179: 305–310. 10.1084/jem.179.1.305 CASPubMedWeb of Science®Google Scholar 78 Llorente, L., W. P. Zou, Y. Levy, Y. Richaudpatin, J. Wijdenes, J. Alcocervarela, B. Morelfourrier, J. C. Brouet, D. Alarconsegovia, P. Galanaud and D. Emilie. 1995. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J. Exp. Med. 181: 839–844. 10.1084/jem.181.3.839 CASPubMedWeb of Science®Google Scholar 79 Llorente, L., Y. Richaud-Patin, J. Wijdenes, J. Alcover-Varela, M. -C. Maillot, I. Durand-Gasselin, B. Morel-Fourrier, P. Galanaud, and D. Emilie. 1993. Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. Eur. Cytokine Network 4: 421–430. CASPubMedWeb of Science®Google Scholar 80 Chernoff, A. E., E. V. Granowitz, L. Shapiro, E. Vannier, G. Lonnemann, J. B. Angel, J. S. Kennedy, A. R. Rabson, S. M. Wolff and C. A. Dinarello. 1995. A randomized, controlled trial of IL-10 in humans—Inhibition of inflammatory cytokine production and immune responses. J. Immunol. 154: 5492–5499. CASPubMedWeb of Science®Google Scholar 81 Wanidworanun, C. and W. Strober. 1993. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis. J. Immunol. 151: 6853–6861. CASPubMedWeb of Science®Google Scholar 82 Platzer, C., C. Meisel, K. Vogt, M. Platzer, and H. D. Volk. 1995. Up-regulation of monocytic IL-10 by tumor necrosis factor-alpha and cAMP elevating drugs. Int. Immunol. 7: 517–523. 10.1093/intimm/7.4.517 CASPubMedWeb of Science®Google Scholar 83 Vanderpoll, T., J. Jansen, M. Levi, H. Tencate, J. W. Tencate, and S. J. Vandeventer. 1994. Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees. J. Exp. Med. 180: 1985–1988. 10.1084/jem.180.5.1985 CASPubMedWeb of Science®Google Scholar 84 Mengozzi, M., G. Fantuzzi, R. Faggioni, A. Marchant, M. Goldman, S. Orencole, B. D. Clark, M. Sironi, F. Benign and P. Ghezzi. 1994. Chlorpromazine specifically inhibits peripheral and brain TNF production, and up-regulates IL-10 production, in mice. Immunology 82: 207–210. CASPubMedWeb of Science®Google Scholar 85 Tarazona, R., A. Gonzalezgarcia, N. Zamzami, P. Marchetti, N. Frechin, J. A. Gonzalo, M. Ruizgayo, N. Vanroouen, C. Martineza, and G. Kroemer. 1995. Chlorpromazine amplifies macrophage-dependent IL-10 production in vivo. J. Immunol. 154: 861–870. CASPubMedWeb of Science®Google Scholar 86 Strassmann, G., V. Patilkoota, F. Finkelman, M. Fong, and T. Kambayashi. 1994. Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E(2). J. Exp. Med. 180: 2365–2370. 10.1084/jem.180.6.2365 CASPubMedWeb of Science®Google Scholar 87 Bourrie, B., M. Bouaboula, J. M. Benoit, J. M. Derocq, M. Esclangon, and P. Casellas. 1995. Enhancement of endotoxin-induced anti-inflammatory cytokine IL10 production by the sigma ligand SR31747 (abstr.), 9th Int. Congr. Immunology, San Francisco , p. 897. Google Scholar 88 Ianaro, A., C. A. O'Donnell, M. DiRosa and F. Y. Liew. 1994. A nitric oxide inhibitor reduces inflammation, down-regulates inflammatory cytokines and enhances interleukin-10 production in carrageenin-induced oedema in mice. Immunology 82: 370–375. CASPubMedWeb of Science®Google Scholar 89 Durez, P., D. Abramowicz, C. GÉrard, M. VanMechelen, Z. Amraoui, C. Dubois, O. Leo, T. Velu, and M. Goldman. 1993. In vivo induction of IL-10 by anti-CD3 mAb or bacterial LPS: Differential modulation by cyclosporin A. J. Exp. Med. 177: 551–555. 10.1084/jem.177.2.551 CASPubMedWeb of Science®Google Scholar 90 Wang, Z. -E., S. Zeng, D. B. Corry, D. K. Dalton, R. A. Seder, S. L. Reiner and R. M. Locksley. 1994. Interferon γ-independent effects of interleukin 12 administered during acute or established infection due to Leishmania major. Proc. Natl. Acad. Sci. U. S. A. 91: 12932–12936. 10.1073/pnas.91.26.12932 CASPubMedWeb of Science®Google Scholar 91 Morris, S. C., K. B. Madden, J. J. Adamovicz, W. C. Gause, B. R. Hubbard, M. K. Gately, and F. D. Finkelman. 1994. Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J. Immunol. 152: 1047–1056. 10.4049/jimmunol.152.3.1047 CASPubMedWeb of Science®Google Scholar 92 SchandenÉ, L., G. DelPrete, E. Cogan, P. Stordeur, A. Crusiaux, B. KennÉs, S. Romagnani, and M. Goldman. 1996. Recombinant interferon-alpha selectively inhibits the production of interleukin-5 by human CD4+ T cells. J. Clin. Invest. 97: 309–315. 10.1172/JCI118417 CASPubMedWeb of Science®Google Scholar 93 Butterfield, J. H. and G. J. Gleich. 1994. Interferon-α treatment of 6 patients with the idiopathic hypereosinophilic syndrome. Ann. Int. Med. 121: 648–653. 10.7326/0003-4819-121-9-199411010-00003 PubMedWeb of Science®Google Scholar 94 TheIFNB Multiple Sclerosis Study Group. 1993. Interferon beta-lb is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43: 655–661. 10.1212/WNL.43.4.655 PubMedGoogle Scholar 95 Chomarat, P., M. -C. Rissoan, J. Banchereau, and P. Miossec. 1993. Interferon γ inhibits interleukin 10 production by monocytes. J. Exp. Med. 177: 523–527. 10.1084/jem.177.2.523 CASPubMedWeb of Science®Google Scholar 96 de Waal Malefyt, R., C. G. Figdor and J. E. de Vries. 1995. Regulation of human monocyte functions by interleukin-10. In Interleukin 10, J. E. Vries and R. Waal Malefyt, Eds.: 37–52. Landes. Austin , Tex . 10.1007/978-3-662-22038-2_5 Google Scholar Citing Literature Volume796, Issue1Cytokines and Adhesion Molecules in Lung InflammationOctober 1996Pages 282-293 ReferencesRelatedInformation
Referência(s)